We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Did you mean microdermabrasion
The government announces its intention to introduce a licensing regime for non-surgical cosmetic procedures such as Botox and fillers.
Cases of benign and malignant neoplasms have been observed among children and adolescents who received treatment with mecasermin. Do not use mecasermin in children or adolescents with active or suspected neoplasia or with any condition or medical history that increases...
Anyone supplying these types of tests should temporarily stop this service.
Employment Tribunal decision.
Dstl funds innovative new technique for treating limb injuries for UK troops
Manufactured by Equipmed and other trading names (listed in the ‘Manufacturer contacts’ section), distributed in the UK by Naturastudios. Do not use affected devices as they have been manufactured to unknown standards and their safety cannot be verified.
Monitor serum phosphate levels in patients treated with multiple high-dose administrations, or those on long-term treatment, and in those with pre-existing risk factors for hypophosphataemia. Re-evaluate ferric carboxymaltose treatment in patients with persistent hypophosphataemia.
(Q-Med AB - a Galderma division) problem with use of Macrolane VRF20 and Macrolane VRF30 for breast augmentation which can make diagnosis of breast cancer more difficult. (MDA/2012/022)
(Merz Pharmaceuticals GmbH) manufacturer has received reports of adverse reactions to the filler. (MDA/2010/064)
The zero response to an FOI asking how many offences of dogs not being microchipped CNC had dealt with
The Medicines and Healthcare products Regulatory Agency (MHRA) has received a total of £970,688 from BEIS’ Regulators’ Pioneer Fund for three projects that aim to unlock cutting edge regulatory innovation, to drive real world benefits for patients, the healthcare sector...
Lower limb protection and a digital forensics tool are the latest technologies to be offered for free licensed commercial exploitation by the Defence Science and Technology Laboratory (Dstl).
The UK will pioneer the world’s largest ocean wildlife monitoring system to help protect life below water as part of the UK Government Blue Belt programme.
Ban on the sale of products containing microbeads comes into effect.
Government announces consultation to ban microbeads in cosmetics and personal care products.
An alert was issued advising against use of Dermapen 3 and Dermapen Cryo Sterile single use needle cartridge tips for Dermapen 3 since their safety cannot be verified.
New Metasurfaces competition, Phase 2 - calling all innovators who can harness materials to transform front-line electromagnetic capability
MSD successfully put their advanced new melanoma treatment through MHRA's early access to medicine scheme (EAMS).
Businesses are being challenged to come up with new ways to minimise the use of animals when researching skin metabolism and gene therapies.
A new advanced imaging centre will receive £81 million government support, housing super-bright lasers to produce state-of-the-art 3D X-rays in just 40 seconds.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).